does glp 1 help with crohn's disease GLP-1 RAs and GLP-1s and Crohn's Disease: Safety,

doi: 10.1016/s0140-6736(65)90761-0

Pratley RE, Aroda VR, Lingvay I, Ldemann J, Andreassen C, Navarria A, et al

However, more serious issues have also been linked to these drugs, including gallbladder problems, low blood sugar, kidney injury and diabetic retinopathy (damage to the eyes retina)

Roche reported ~CHF 61.5 billion ($78.6 billion) in total sales, driven by strong pharmaceuticals growth, though Roche does not break out standalone revenue for Genentech publicly

However, as of now, the FDA has approved GLP-1 drugs only in the form of injections and pills 1 , 2 , and there are no approved form of GLP-1 transdermal (skin) patches which are in medical use